Weight Management
Tirzepatide.
LY3298176
Dual GLP-1 / GIP incretin agonism. Trial endpoints and comparison points to single-pathway agonists.
Educational framing only. Sources for mechanism, preclinical findings, and handling notes are linked inline in the long-form research notes. Detailed write-up is in preparation and will appear here.